Epilepsy

Overview

Epilepsy is a chronic neurological disorder characterized by recurrent unprovoked seizures, affecting ~50 million people worldwide. Approximately 30% of patients have drug-resistant epilepsy — a population where microbiome-targeted interventions (particularly the ketogenic diet) have shown the most clinical impact.

The gut microbiome's role in epilepsy operates through the gut brain axis: microbially-derived neuroactive metabolites (kynurenine pathway products, GABA, serotonin, SCFAs) directly modulate neuronal excitability and seizure thresholds.

Microbiome Associations

Cerebral Palsy-Epilepsy Comorbidity

Children with cerebral palsy plus epilepsy (CP+E) have distinct gut microbiota compared to CP without epilepsy, suggesting epilepsy is not merely a neurological overlay but involves gut-brain axis restructuring [1], [2].

Causal Evidence (Mendelian Randomization)

MR supports a causal link between specific gut microbiota and epilepsy risk, though the specific taxa remain under investigation [3].

Kynurenine Pathway

The kynurenine pathway produces metabolites with opposing neurological effects:

  • Kynurenic acid (KA): Neuroprotective NMDA antagonist; may raise seizure threshold.
  • Quinolinic acid (QUIN): Neurotoxic NMDA agonist; may lower seizure threshold.
  • The KA/QUIN balance, modulated by gut microbiome composition and inflammation, may influence seizure susceptibility.

Ketogenic Diet and the Microbiome

The ketogenic diet is the most evidence-based microbiome-modulating intervention for drug-resistant epilepsy:

  • Dramatically reshapes gut microbiome composition within days.
  • Increases akkermansia muciniphila and decreases enterobacteriaceae in animal models.
  • Produces ketone bodies (BHB) that have anti-inflammatory and neuroprotective effects, including tlr4 inhibition.
  • The microbiome changes may be causally required for the anti-seizure effect: antibiotic ablation of the microbiome eliminated ketogenic diet efficacy in mice [4].

Cross-References

References (5)

  1. Congfu Huang, Yinhu Li, Xin Feng et al. (2019). Huang 2019 — Distinct Gut Microbiota Composition and Functional Category in Children With Cerebral Palsy and Epilepsy. Frontiers in Pediatrics. doi:10.3389/fped.2019.00394
  2. Peng A, et al. (2023). Peng 2023 — Gut Microbiome and Brain Metabolic Remodeling in CP with Epilepsy. Frontiers in Neurology. doi:10.3389/fneur.2023.1109469
  3. Youjie Zeng, Si Cao, Heng Yang (2023). Roles of gut microbiome in epilepsy risk: a Mendelian randomization study. Frontiers in Microbiology. doi:10.3389/fmicb.2023.1115014
  4. Anna Gudan, Ewa Stachowska (2022). Gudan 2022 — The Potential Impact of the Ketogenic Diet on Gut Microbiota in the Context of Neurological Disorders. Advances in Hygiene and Experimental Medicine. doi:10.2478/ahem-2022-0019
  5. Congfu Huang, Chunuo Chu, Yuanping Peng et al. (2022). Huang 2022 — Correlations Between Gastrointestinal and Oral Microbiota in Children With Cerebral Palsy and Epilepsy. Frontiers in Pediatrics. doi:10.3389/fped.2022.988601

Related Articles